Biology News
Study Guide for Pharmacology. A Patient-Centered Nursing Process Approach. Edition No. 9 - satPRnews (press release)


satPRnews (press release)
The new report from Pharmaceuticals Market Reports has been published today. It provides updated in 2018 year analysis of pharmaceutical industries. Corresponding to the chapters in McCuistion's Pharmacology: A Patient-Centered Nursing Process Approach ...

Endocannabinoids, Vol 125. International Review of Neurobiology - MilTech


MilTech
The new report from Pharmaceuticals Market Reports has been published today. It provides updated in 2018 year analysis of pharmaceutical industries. Endocannabinoids, the latest volume in the International Review of Neurobiology series is a ...

Neuroprotective Agents and Cerebral Ischaemia, Vol 40. International Review of Neurobiology - satPRnews (press release)


satPRnews (press release)
The new report from Pharmaceuticals Market Reports has been published today. It provides updated in 2018 year analysis of pharmaceutical industries. Since 1959, International Review of Neurobiology has been a well-known series appealing to ...

Isis Pharmaceuticals Inc.

Englewood - United States

Discovers and develops drugs based upon antisense and RNAi technology. Focused on RNA as a therapeutic target. Includes overview of recent research and drug development approaches.

Related
AFT Pharmaceuticals - A New Force In Pharmaceuticals
New Zealand

AFT Pharmaceuticals is a privately owned company with operations in both Australia and New Zealand. The company was founded in 1997 by Dr Hartley Atkinson. AFT operates as a full service pharmaceutical company and also undertakes drug development activities including clinical trials. AFT has a growing portfolio of patented and niche pharmaceuticals which are in the process of being licensed for sale outside the Australasian market.

Australia

Endangered tree in Queensland, Australia. Includes a description and information on its distribution, habitat, threats and recovery plan.

Prolexys Pharmaceuticals, Inc.
United States

Mapping protein-protein interactions and identify new targets for drug discovery to treat cancer and cardiovascular disease. Explains technology platforms and aetology targeted, with FAQ, company alliances and management in Salt Lake City, Utah.

MultiTarget Pharmaceuticals
United States

Manufacturer of AquaPlasmid, a system for the isolation of pure plasmid DNA. The procedure is simpler than alkaline lysis, but the DNA prep is purer than those purified by anion exchange columns, in Salt Lake City, Utah, USA.

Alnylam Pharmaceuticals
United States

Develops novel therapeutics based RNAi. Provides overview of recent drug development programs. Includes company profile and technology information.

Calando Pharmaceuticals
United States

Company developing non-viral technologies for the therapeutic use of RNAi.

RXi Pharmaceuticals
United States

Discovery-stage biotechnology company pursuing the development of RNAi therapeutics for the treatment of neurodegenerative disease, diabetes and obesity.

Quantum Pharmaceuticals
United States

Provides drug discovery using computational technology to simulates intermolecular interactions.

United States

Develops and researches proprietary immunoregulatory compounds for treatment of autoimmune and cardiovascular disorders, inflammation and cancer. Provides information about products and technologies, as well as corporate and investment data. New Haven, CT.

Beximco Pharmaceuticals Ltd.
Bangladesh

Beximco Pharmaceuticals Ltd (BPL) is a leading manufacturer of pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs) in Bangladesh. The company is one of the largest exporter of pharmaceuticals in the country and its state-of-the-art manufacturing facilities are certified by global regulatory bodies of Australia, European Union, Gulf nations, Brazil, among others. The company is consistently building upon its portfolio and curr